SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-458471
Filing Date
2016-02-11
Accepted
2016-02-11 06:13:06
Documents
8
Period of Report
2016-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d110122d8k.htm 8-K 24192
2 EX-1.1 d110122dex11.htm EX-1.1 161112
3 EX-4.1 d110122dex41.htm EX-4.1 126037
4 EX-4.2 d110122dex42.htm EX-4.2 34506
5 EX-5.1 d110122dex51.htm EX-5.1 6354
6 EX-99.1 d110122dex991.htm EX-99.1 10191
7 EX-99.2 d110122dex992.htm EX-99.2 11095
8 GRAPHIC g110122g11a67.jpg GRAPHIC 4437
  Complete submission text file 0001193125-16-458471.txt   381138
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 161407765
SIC: 2834 Pharmaceutical Preparations